DNA Vaccination with a Single‐Plasmid Construct Coding for Viruslike Particles Protects Mice against Infection with a Highly Pathogenic Avian Influenza A Virus
Author(s) -
Judit Szécsi,
Gülşah Gabriel,
Gabriella Edfeldt,
Maud Michelet,
Hans Dieter Klenk,
FrançoisLoïc Cosset
Publication year - 2009
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/599840
Subject(s) - virology , biology , immunogenicity , influenza a virus subtype h5n1 , dna vaccination , vaccination , hemagglutinin (influenza) , virus , pandemic , influenza a virus , antigenic drift , microbiology and biotechnology , antibody , plasmid , gene , infectious disease (medical specialty) , genetics , medicine , covid-19 , disease , pathology
With seasonal outbreaks affecting millions of people each year and devastating pandemics, human influenza is a major health concern. The pandemic threat includes highly pathogenic avian influenza viruses (HPAIVs) that gained the ability to infect humans in Asia and quickly spread throughout the world. Major concerns have been raised regarding today's vaccine production systems against influenza viruses, and new strategies to design efficient vaccines are under intensive investigation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom